Breaking News Instant updates and real-time market news.

CAG

Conagra Brands

$34.24

0.55 (1.63%)

, JNJ

Johnson & Johnson

$130.67

0.77 (0.59%)

04:55
09/07/17
09/07
04:55
09/07/17
04:55

Barclays to hold a conference

Global Consumer Staples Conference is being held in Boston on September 5-7.

CAG

Conagra Brands

$34.24

0.55 (1.63%)

JNJ

Johnson & Johnson

$130.67

0.77 (0.59%)

KO

Coca-Cola

$45.96

0.04 (0.09%)

SAFM

Sanderson Farms

$150.42

0.77 (0.51%)

SJM

J.M. Smucker

$106.21

0.13 (0.12%)

CL

Colgate-Palmolive

$71.49

0.38 (0.53%)

TAP

Molson Coors

$88.72

-0.16 (-0.18%)

K

Kellogg

$67.84

1.44 (2.17%)

MO

Altria Group

$63.27

0.4 (0.64%)

VGR

Vector Group

$21.13

-0.49 (-2.27%)

NWL

Newell Brands

$47.03

-1.69 (-3.47%)

USFD

US Foods

$27.26

-0.18 (-0.66%)

ELF

e.l.f. Beauty

$20.39

0.67 (3.40%)

SYY

Sysco

$52.91

-0.11 (-0.21%)

  • 07

    Sep

  • 08

    Sep

  • 11

    Sep

  • 12

    Sep

  • 14

    Sep

  • 22

    Sep

  • 22

    Sep

  • 27

    Sep

  • 27

    Sep

  • 16

    Nov

CAG Conagra Brands
$34.24

0.55 (1.63%)

08/28/17
UBSW
08/28/17
NO CHANGE
Target $65
UBSW
Buy
UBS believes Pinnacle Food/Conagra deal could yield sizable synergies
UBS analyst Steven Strycula explored five scenarios for Pinnacle Foods (PF) to create shareholder value, one of which is a combination with Conagra (CAG). The analyst believes a tie-up could deliver earnings accretion and sizable synergies within the frozen and condiment/dressing categories. He also said Pinnacle could make bolt-on acquisitions that could represent a transformational asset for larger, growth challenged sponsors. Strycula reiterated his Buy rating and $65 price target on Pinnacle Foods shares.
06/30/17
UBSW
06/30/17
NO CHANGE
Target $33
UBSW
Sell
Conagra Brands valuation remains elevated given fundamentals, says UBS
UBS analyst Steven Strycula believes the valuation for Conagra Brands remains elevated given its current fundamentals. The analyst cut his estimates to reflect lower sales and more muted upside for margins. Strycula said the breadth of the company's portfolio makes it challenging to move the needle, but he expects its robust innovation pipeline to boost sales beginning next year. Strycula reiterated his Sell rating and lowered his price target to $33 from $35 on Conagra Brands shares.
07/26/17
JEFF
07/26/17
NO CHANGE
Target $50
JEFF
Buy
Hain Celestial management would sell at right price, says Jefferies
After hosting investor meetings with management, Jefferies analyst Akshay Jagdale performed additional work to quantify Hain Celestial's (HAIN) strategic value. The analyst believes there would be "significant strategic interest" in Hain and that management "is a willing seller" at the right price. A deal for Hain makes the most sense for Pinnacle Foods (PF), Jagdale tells investors in a research note. He analyzed five scenarios in which hypothetical strategic buyers acquire Hain for $70 per share. The organic and natural products company closed yesterday up 1c to $43.80. Jagdale estimates that by year three, the deal would be 8% accretive to Pinnacle's earnings, 4% to General Mills' (GIS) and Conagra Brands' (CAG), 1.4% to Campbell Soup's and dilutive to Kellogg's (K). The analyst sees limited downside to shares of Hain and keeps a Buy rating on the stock with a $50 price target.
07/06/17
JEFF
07/06/17
NO CHANGE
Target $46
JEFF
Buy
Conagra Brands weakness a buying opportunity, says Jefferies
Jefferies analyst Akshay Jagdale views the recent weakness in shares of Conagra Brands as a buying opportunity. The company's guidance is likely conservative and its portfolio reshaping, which the market is missing, has the potential to unlock "significant" value, Jagdale tells investors in a research note. He reiterates a Buy rating on Conagra with a $46 price target.
JNJ Johnson & Johnson
$130.67

0.77 (0.59%)

08/14/17
BTIG
08/14/17
UPGRADE
Target $100
BTIG
Buy
Masimo upgraded to Buy, could be acquired by Johnson & Johnson, says BTIG
BTIG analyst Sean Lavin upgraded Masimo (MASI) to Buy from Neutral with a $100 price target saying he is more bullish on the Philips (PHG) agreement leading to increased revenue and margins, and the recent share pullback has provided a buying opportunity. Lavin said Masimo has been executing "superbly" and believes the Philips' relationship will drive acceptance of hemoglobin and Rainbow. Further, the analyst thinks Johnson & Johnson (JNJ) could be an acquirer of Masimo as it sells its products into the OR and ICU markets and would "massively" expand operating margins, and notes Philips may see the value of Masimo's products and make a bid.
08/02/17
PIPR
08/02/17
NO CHANGE
Target $7
PIPR
Overweight
Imbruvica approval in graft versus host positive for Kadmon, says Piper Jaffray
After the FDA expanded the approval of AbbVie (ABBV) and Johnson & Johnson's (JNJ) Imbruvica for the treatment of adults with chronic graft versus host disease, or cGVHD, Piper Jaffray analyst Edward Tenthoff said he views the news as positive for Kadmon's KD025. Imbruvica is tough for patients to tolerate, said Tenthoff, who sees an opportunity for KD025 to more safely treat cGVHD patients. He keeps an Overweight rating and $7 price target on Kadmon shares.
08/31/17
UBSW
08/31/17
NO CHANGE
Target $148
UBSW
Buy
Johnson & Johnson remain a top pick, says UBS
UBS analyst Matt Miksic met with Johnson & Johnson management and came away remaining confident in his conviction of his bullish view on the company. The analyst sees sustained Pharma growth, stable Med Device growth and an improving Consumer division. He identifies multiple drivers, including its pipeline and potential deal interest in Eye Care, Dental, Structural Heart and Neurology. Miksic reiterated his Buy rating and $148 price target on the stock, adding Johnson & Johnson remains a top pick.
08/16/17
JPMS
08/16/17
NO CHANGE
Target $148
JPMS
Overweight
Johnson & Johnson price target raised ahead of ESC meeting at JPMorgan
JPMorgan analyst Michael Weinstein raised his price target for Johnson & Johnson shares to $148 from $140 ahead of the European Society of Cardiology beginning on August 26. The big event for J&J is the presentation of the COMPASS trial, investigating the use of Xarelto for the treatment of coronary or peripheral artery disease, Weinstein tells investors in a research note. His statistical analysis suggests a minimum 25% reduction in major adverse cardiac events, or MACE. This would make COMPASS a "landmark event in the treatment of CAD/PAD" and lead to Xarelto being adopted as the new standard of care in this greater than $5B indication, Weinstein writes. He recommends buying J&J shares ahead of the European Society of Cardiology meeting and keeps an Overweight rating on the name.
KO Coca-Cola
$45.96

0.04 (0.09%)

06/07/17
BMOC
06/07/17
DOWNGRADE
BMOC
Market Perform
Coca-Cola downgraded on valuation at BMO Capital
As noted earlier, BMO Capital downgraded Coca-Cola to Market Perform from Outperform. Analyst Amit Sharma downgraded the stock based on valuation. Target remains $46.
04/19/17
04/19/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Goldman Sachs (GS) upgraded to Neutral from Sell at Citi with analyst Keith Horowitz saying yesterday's post-earnings selloff took out the excess valuation premium. The analyst believes the risk/reward is now more balanced. He keeps a $225 price target for Goldman shares. 2. HP Inc. (HPQ) upgraded to Overweight from Equal Weight at Barclays with analyst Mark Moskowitz saying he expects earnings to return later this year amid improving PC trends and the end of the printing supplies glut. 3. WestRock (WRK) upgraded to Outperform from Sector Perform at RBC Capital and to Buy from Neutral at Goldman Sachs. 4. Coca-Cola (KO) upgraded to Outperform from Neutral at Credit Suisse with analyst Laurent Grandet saying with incoming CEO James Quincey taking over on May 1, and the refranchising nearly complete, Coca-Cola "has all the pieces in place to be successful again." The company has "significant balance sheet flexibility" to invest in the business and fill the gaps in the current portfolio, the analyst adds. 5. Fastenal (FAST) upgraded to Outperform from Neutral at Credit Suisse with analyst Andrew Buscaglia saying the selloff since the first quarter report has created a buying opportunity. The analyst views Fastenal as a best-in-class distributor with significant manufacturing exposure with very high operating leverage in an upcycle. Buscaglia said a recent private distributor survey indicates a majority of respondents expect price increases over the next three months and believe the company may be able to increase prices, which would surprise the Street. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/07/17
06/07/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. PepsiCo (PEP) and Coca-Cola (KO) were downgraded to Market Perform from Outperform at BMO Capital. 2. Rent-A-Center (RCII) downgraded to Sell from Hold at Loop Capital with analyst Anthony Chukumba saying the secular shift to "virtual" rent-to-own has impaired the value of the company's core U.S. business. 3. HD Supply (HDS) was downgraded to Neutral from Outperform at Baird and to Hold from Buy at Drexel Hamilton. 4. IMAX (IMAX) downgraded to Hold from Buy at Benchmark with analyst Mike Hickey saying he fears movie goers' enthusiasm for recliner installations has shifted share away from IMAX and he now worries that recent per screen average deterioration could "prove less than transitory." 5. Danaher (DHR) downgraded to Neutral from Buy at Janney Capital with analyst Paul Knight saying he sees the company having more work to do optimizing its portfolio. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/07/17
BMOC
06/07/17
DOWNGRADE
BMOC
Market Perform
Coca-Cola downgraded to Market Perform from Outperform at BMO Capital
SAFM Sanderson Farms
$150.42

0.77 (0.51%)

08/17/17
SPHN
08/17/17
DOWNGRADE
Target $145
SPHN
Equal Weight
Sanderson Farms downgraded to Equal Weight from Overweight at Stephens
Stephens analyst Farha Asiam downgraded Sanderson Farms to Equal Weight citing valuation as shares are near his $145 price target.
06/12/17
KEYB
06/12/17
DOWNGRADE
KEYB
Sector Weight
Sanderson Farms downgraded to Sector Weight from Overweight at KeyBanc
KeyBanc analyst Brett Andress downgraded Sanderson Farms to Sector Weight citing valuation with the shares up 28% since his March 26 upgrade. The analyst sees a more balanced risk/reward at current share levels and recommends taking profits in the name.
06/12/17
06/12/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Apple (AAPL) downgraded to Neutral from Buy at Mizuho with analyst Abhey Lamba saying "Enthusiasm" around the upcoming iPhone launch is fully priced in after the stock's year-to-date outperformance. 2. Adobe (ADBE) downgraded to Sell from Hold at Pivotal Research with analyst Brian Wieser citing valuation. 3. Pandora (P) downgraded to Perform from Outperform at Oppenheimer with analyst Jason Helfstein citing a "failure" of his takeout thesis. The capital investment from SiriusXM (SIRI) and Ticketfly will allow Pandora to refocus on its core advertising business, which is the correct strategy, Helfstein tells investors in a research note. He sees share upside to "only" $9.50-$11.00 and removed his $14 price target on the stock. 4. Vantiv (VNTV) downgraded to Sector Weight from Overweight at Pacific Crest with analyst Josh Beck saying "continued retail challenges" could limit fundamental upside. 5. Sanderson Farms (SAFM) downgraded to Sector Weight from Overweight at KeyBanc with analyst Brett Andress citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/17/17
08/17/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Illinois Tool Works (ITW) downgraded to Underweight from Neutral at JPMorgan with analyst Ann Duignan citing valuation and expectations for continued multiple compression on weaker than peer organic growth. The analyst lowered her price target for the shares to $132 from $141. 2. Boston Properties (BXP) downgraded to Outperform from Top Pick at RBC Capital with analyst Michael Carroll saying he thinks that upcoming move-outs by the REIT's tenants, along with slower than expected macro economic growth, will negatively impact its growth. 3. Sanderson Farms (SAFM) downgraded to Equal Weight from Overweight at Stephens with analyst Farha Asiam citing valuation. 4. Nucor (NUE) downgraded to Sector Weight from Overweight at KeyBanc with analyst Philip Gibbs citing spread and volume pressures. 5. Netshoes (NETS) downgraded to Hold from Buy at Jefferies with analyst Brian Fitzgerald citing continuing softness in the consumption environment in Brazil as well as limited visibility into near-term operating results. The analyst lowered his price target for the shares to $18.50 from $22. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
SJM J.M. Smucker
$106.21

0.13 (0.12%)

08/24/17
08/24/17
DOWNGRADE
Target $116

Neutral
J.M. Smucker downgraded on challenged coffee, pet food outlook at JPMorgan
As previously reported, JPMorgan analyst Ken Goldman downgraded J.M. Smucker to Neutral from Overweight after the company's Q1 earnings report and guidance cut, stating that it is becoming "increasingly clear" that the company's position within the categories of coffee and pet food is "highly challenged." While the company lowered guidance, he does not think it cut its forecast enough, Goldman tells investors. He lowered his FY18 and FY19 estimates for J.M. Smucker and dropped his price target on the stock to $116 from $135. J.M. Smucker shares are down 6.6% to $111 in pre-market trading.
08/25/17
SBSH
08/25/17
NO CHANGE
SBSH
Buy
J.M. Smucker the 'cheapest' large cap stock in U.S. Food, says Citi
Citi analyst David Driscoll said J.M. Smucker management has taken corrective actions to address coffee price gaps to private label and in the second half of the year he expects coffee cost comparisons to improve and for K-cup contract renegotiations to be a benefit. The analyst, who called J.M. Smucker the "cheapest stock in large cap, U.S. Food," keeps a Buy rating on the shares, which declined 9.5% to $107.51 yesterday after the company's earnings report and guidance cut.
08/24/17
JPMS
08/24/17
DOWNGRADE
JPMS
Neutral
J.M. Smucker downgraded to Neutral from Overweight at JPMorgan
08/24/17
08/24/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Teva (TEVA) downgraded to Underperform from Neutral at Credit Suisse by analyst Vamil Divan, saying that while Teva has dramatically reduced 2017 guidance, the core challenges they are facing should not fade anytime soon. The analyst pointed out that pricing pressure and increased competition in the U.S. generics business will remain, the appointment of a full-time CEO is still pending and the threat of generic competition to Copaxone 40mg still looms. 2. Lowe's (LOW) downgraded to Market Perform from Outperform at BMO Capital by analyst Wayne Hood based on the company's results and guidance which he said were "disappointing." The analyst expects the company's profitability to remain "challenged" going forward. 3. Dick's Sporting (DKS) downgraded to Market Perform from Outperform at Cowen, saying it had overestimated the company's ability to achieve its prior guidance and maintain its profitability. Cowen pointed to a number of headwinds for Dick's, including increasing digital competition and the negative side of industry cyclical trends. 4. J.M. Smucker (SJM) downgraded to Neutral from Overweight at JPMorgan. 5. LaSalle Hotel (LHO) downgraded to Neutral from Outperform at Boenning & Scattergood by analyst Floris van Dijkum citing recent share outperformance and potential declining comparable EBITDA that could pressure future NAV. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CL Colgate-Palmolive
$71.49

0.38 (0.53%)

04/10/17
DBAB
04/10/17
NO CHANGE
DBAB
Deutsche sees Personal Care stocks giving up recent gains
Deutsche Bank analyst Faiza Alwy expects stocks in the Cosmetics, Household and Personal Care space to give up their recent gains. The market seems to have decided that 3G or Unilever (UN, UL) is interested in acquiring U.S. HPC stocks with the group up 11% year-to-date, Alwy tells investors in a research note. The analyst sees M&A as unlikely in the near-term and points out that interest rates are rising. Alwy keeps Hold ratings on Colgate-Palmolive (CL), Clorox (CLX), Edgewell Personal Care (EPC) and Kimberly-Clark (KMB).
04/18/17
JEFF
04/18/17
INITIATION
Target $78
JEFF
Hold
Colgate-Palmolive initiated with a Hold at Jefferies
Jefferies analyst Kevin Grundy started Colgate-Palmolive with a Hold rating and $78 price target. The analyst views the sock as fully valued at current levels.
03/21/17
JPMS
03/21/17
INITIATION
Target $77
JPMS
Neutral
Colgate-Palmolive initiated with a Neutral at JPMorgan
JPMorgan analyst Andrea Teixeira started Colgate-Palmolive with a Neutral rating and $77 price target.
05/17/17
JEFF
05/17/17
NO CHANGE
JEFF
Jefferies sees Unilever as interested if Colgate is for sale
After the New York Post reported that Colgate (CL) may be willing to sell for $100 per share, Jefferies analyst Martin Deboo says he'd expect Unilever (UN, UL) to be an interested party. The analyst notes he's argued for some time that Unilever should create a "New World Order" in Household & Personal Care by acquiring Colgate. Such a deal would support his bullish thesis on Unilever shares.
TAP Molson Coors
$88.72

-0.16 (-0.18%)

05/04/17
FBCO
05/04/17
NO CHANGE
Target $95
FBCO
Neutral
Molson Coors price target lowered to $95 from $106 at Credit Suisse
Credit Suisse analyst Credit Suisse lowered his price target for Molson Coors to $95 from $106 after Q1 results disappointed investors as sales were broadly in line but EBITDA declined nearly 4% due to an unexpected spike in MG&A costs that management said was attributed to "investing ahead of the curve." The analyst reiterates a Neutral rating on the shares.
05/04/17
05/04/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Garmin (GRMN) downgraded to Underweight from Neutral at JPMorgan with analyst Paul Coster citing valuation and less likelihood for upside surprises throughout the remainder of 2017 due to tough comparisons. The analyst lowered his price target for the shares to $50 from $55. 2. Square (SQ) downgraded to Neutral from Buy at Guggenheim with the firm citing valuation and maintained a $20 price target on shares. 3. Tractor Supply (TSCO) downgraded to Perform from Outperform at Oppenheimer with analyst Brian Nagel citing concerns about the company's "modest" earnings growth could drive multiple contraction. The analyst thinks a guidance cut is likely when Tractor reports second quarter results in July. 4. Molson Coors (TAP) downgraded to Hold from Buy at Societe Generale with analyst Andrew Holland saying investments will impact margins. 5. MEDNAX (MD) downgraded two notches to Underperform from Buy at BofA/Merrill with the firm's analyst citing concerns cost pressures and worsening top line trends. The analyst lowered its price target to $57 from $75. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/04/17
SOCG
05/04/17
DOWNGRADE
Target $98
SOCG
Hold
Molson Coors downgraded to Hold, 2017 a transition year, says Societe Generale
Soceite General analyst Andrew Holland downgraded Molson Coors to Hold from Buy and lowered its price target to $98 from $117 saying investments will impact margins. Molson's CEO said 2017 is a "transition" year as the company invests in several areas that should improve competitiveness, but will largely offset the cost savings from the Miller integration, the analyst believes. Holland cut Molson earnings estimates to reflect the increased spend and said concerns over US trade and Mexico and Ingredion's performance are concerning.
04/20/17
04/20/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Amazon.com (AMZN) downgraded to Peer Perform from Outperform at Wolfe Research with analyst Scott Mushkin saying shares are approaching his price target and he expects increasing competition through year-end. 2. Time Warner (TWX) downgraded to Hold from Buy at Pivotal Research with analyst Brian Wieser saying shares are trading near the value of AT&T's (T) offering price. 3. Molson Coors (TAP) downgraded to Market Perform from Outperform at Cowen with analyst Vivien Azer citing expectations for persistent beer volume headwinds. The analyst believes alcohol consumption could be pressured for at least the next decade, partly due to increased cannabis use, and a contraction in the alcohol cycle. Azer said Molson is uniquely exposed to the increasingly vibrant and growing cannabis markets and notes there is an inverse relationship between cannabis use and alcohol consumption over time. 4. eBay (EBAY) downgraded to Neutral from Buy at Monness Crespi with analyst James Cakmak saying he sees insufficient upside to estimates to justify the lofty valuation. The analyst said the path to double-digit growth may be pushed out 2019 and limited potential to outperform topline expectations in 2017. Further, the analyst sees margin pressures from product mix towards StubHub and rising development spend for the backend, and limited opportunities for multiple expansion. 5. Ruth's Hospitality (RUTH) downgraded to Market Perform from Outperform at Raymond James with analyst Brian Vaccaro citing valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
K Kellogg
$67.84

1.44 (2.17%)

05/24/17
PIPR
05/24/17
INITIATION
PIPR
Overweight
Kellogg initiated with an Overweight at Piper Jaffray
Piper Jaffray analyst Michael Lavery initiated Kellogg with an Overweight rating and $78 price target, saying he sees accelerating EPS growth into 2018 driven by average margin expansion.
05/24/17
PIPR
05/24/17
INITIATION
PIPR
Neutral
Kraft Heinz initiated with a Neutral at Piper Jaffray
Piper Jaffray analyst Michael Lavery initiated Kraft Heinz with a Neutral rating and $94 price target, expecting Kraft Heinz will pursue further consolidation, with Kellogg (K) and PepsiCo (PEP) looking like the best fit of the company's stated M&A criteria.
08/04/17
JPMS
08/04/17
UPGRADE
Target $78
JPMS
Overweight
Kellogg upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Ken Goldman upgraded Kellogg to Overweight and raised his price target for the shares to $78 from $76. The analyst views the risk/reward as appealing with the Street's 2018 EBIT margin estimate 50 basis points below guidance, Direct Store Delivery execution risk largely behind the company an easier comps approaching in U.S. cereal.
MO Altria Group
$63.27

0.4 (0.64%)

08/30/17
MSCO
08/30/17
NO CHANGE
MSCO
Overweight
British American Tobacco recent weakness appears overdone, says Morgan Stanley
Morgan Stanley analyst Matthew Grainger said he views some degree of weakness in U.S. and European tobacco stocks since "FDA Friday" - when the agency announced plan to pursue reduced nicotine content in cigarettes - as warranted, but he views the impact on British American Tobacco (BTI) as being overstated by the stock's 11% pullback. For Altria Group (MO), which is down 14% since that day, he sees the move as having returned the stock to appropriate valuation levels, he added. Grainger lowered his price target for Altria to $65 from $68, kept his Philip Morris (PM) price target of $120 unchanged and maintains his British American target at GBP60.
07/31/17
WELS
07/31/17
NO CHANGE
WELS
Altria Group still likely to be acquired after FDA news,says Wells Fargo
After the FDA announced a new approach towards nicotine Friday, Wells Fargo expects Altria (MO) to be "a big beneficiary" of the approach, since it will spur much higher purchases of reduced-risk products and smokeless cigarettes, leading to share gains for Altria, according to the firm. Wells believes that the FDA's announcement may increase the value of Altria to "close to $90 per share" from $80 per share previously, and it continues to expect the company to be acquired by Philip Morris (PM). Wells thinks that tobacco stocks could experience an "overhang in the near-term," but it says the news "could be positive" for the sector over the longer term, as it thinks the large tobacco companies will ultimately benefit from the change in consumption trends. British American Tobacco (BTI) is another publicly traded company in the sector.
07/31/17
07/31/17
UPGRADE
Target $62

Sector Perform
Altria Group upgraded to Sector Perform at RBC Capital
As previously reported, RBC Capital analyst Nik Modi upgraded Altria Group to Sector Perform from Underperform, as he believes the FDA's tobacco announcement on Friday was "very much in line" with industry expectations despite the surprise to investors. Modi, who still thinks tobacco stocks can perform despite major overhangs, keeps a $62 price target on Altria.
07/31/17
07/31/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Altria Group (MO) upgraded to Sector Perform from Underperform at RBC Capital with analyst Nik Modi saying he believes the FDA's tobacco announcement on Friday was "very much in line" with industry expectations despite the surprise to investors. 2. American Airlines (AAL) upgraded to Outperform from Market Perform at Cowen. 3. Baidu (BIDU) upgraded to Buy from Neutral at Nomura Instinet with analyst Jialong Shi-NIHK citing accelerating revenue momentum driven by news feed ads and an undervalued video business. 4. Wells Fargo (WFC) upgraded to Market Perform from Underperform at BMO Capital with analyst James Fotheringham citing valuation. The firm also ended its pair trade call of going long Citi (C) and short Wells Fargo. 5. GoPro (GPRO) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Yuuji Anderson saying valuation better reflects efforts to driver better product cycles through software improvements. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
VGR Vector Group
$21.13

-0.49 (-2.27%)

NWL Newell Brands
$47.03

-1.69 (-3.47%)

08/07/17
JPMS
08/07/17
NO CHANGE
Target $61
JPMS
Overweight
Newell Brands pullback Friday a buying opportunity, says JPMorgan
JPMorgan analyst Andrea Teixeira views Friday's post-earnings pullback in shares of Newell Brands as a buying opportunity. Investors have overreacted to a small sales miss, Teixeira tells investors in a research note. He expects the company's sales to accelerate into Q3 and Q4 and keeps an Overweight rating on the name. The analyst lowered his price target for Newell shares to $61 from $64.
08/07/17
KEYB
08/07/17
NO CHANGE
KEYB
Newell Brands should be bought on weakness, says KeyBanc
After Newell reported lower than expected sales, KeyBanc analyst Jason Gere says the company reported "solid" results and can meet tis 2H17 guidance. He reiterates a $60 price target and recommends buying the shares on weakness.
06/26/17
MSCO
06/26/17
NO CHANGE
Target $204
MSCO
Overweight
Constellation Brands no longer a Top Pick post run-up at Morgan Stanley
Morgan Stanley analyst Dara Mohsenian continues to expects Constellation Brands (STZ) to report another solid quarter above Q1 consensus estimates but said expectations are somewhat high and shares are up nearly 30% since January. The analyst is switching to Newell Brands (NWL) as a Top Pick and out of Constellation Brands following recent share strength. Mohsenian maintains an Overweight on Constellation with a $204 price target due to high earnings visibility and believes the market is mispricing long-term growth potential.
06/01/17
JEFF
06/01/17
NO CHANGE
JEFF
Jefferies reiterates Monster, Newell as top picks
Jefferies analyst Kevin Grundy reiterates Monster Beverage (MNST) and Newell Brands (NWL) as top picks while addressing "common investor pushbacks." For Monster, the analyst believes improving U.S. results, continued strong international growth and M&A optionality should lead to continued outperformance. For Newell, the analyst sees an attractive valuation and improving organic sales growth. He reiterates Buy ratings on both names.
USFD US Foods
$27.26

-0.18 (-0.66%)

08/10/17
RBCM
08/10/17
NO CHANGE
RBCM
US Foods outlook remains positive, says RBC Capital
RBC Capital analyst William Kirk says that US Foods' comments about slower revenue growth in 2H17 shouldn't be surprising, as its comp got harder.The analyst still expects the company to gain share and generate high single digit adjusted EBITDA growth. He reiterates a $32 price target and an Outperform rating on the shares.
06/26/17
GUGG
06/26/17
NO CHANGE
GUGG
Food distributor decline 'seems overdone,' says Guggenheim
Guggenheim analyst John Heinbickel says that the decline of food distributors in the wake of Amazon's (AMZN) acquisition of Whole Foods (WFM) "seems overdone." The analyst thinks the notion that Amazon will look to enter the food distribution business is "highly unlikely...especially in the near to intermediate term". He says that such an initiative would require "a separate, dedicated supply chain as well as a field-level sales force," both of which would be "challenging" to launch. The analyst adds that customers in the sector have "inertia," especially vis-a-vis fresh food. He recommends buying food distributors Performance Food Group (PFGC) and US Foods (USFD) on weakness.
08/08/17
WELS
08/08/17
NO CHANGE
WELS
Food distributors outlook positive into June quarter results, says Wells Fargo
Wells Fargo says that sentiment on the food distributors has deteriorated due to worries about inflation and Amazon's (AMZN)possible entry into the space. However, the firm thinks that inflation is "a net positive" for the sector, while the three largest companies in the sector look set to benefit from share gains and M&A accretion. Wells is most upbeat on US Foods (USFD)and Sysco (SYY), citing reductions in their valuation and their efforts to increase volume and margins. Wells thinks the stocks have reached attractive entry points as it believes that investors are exaggerating the Amazon threat. It keeps Outperform ratings on US Foods and Sysco.
08/10/17
WELS
08/10/17
NO CHANGE
WELS
US Foods has reached attractive entry point, says Wells Fargo
Wells Fargo says that US Foods has reached an attractive entry point after it fell 4.6% following its Q2 results. Wells says that the company's results were solid, and it believes that most of the concerns about them relate to "transitory" issues. Wells expects the company's gross margins to rebound in 2H17 as inflation slows, and it thinks that the 5.5% increase in the company's Q2 gross profit is much more meaningful than the slight decline in its gross margins. It keeps an Outperform rating on the stock.
ELF e.l.f. Beauty
$20.39

0.67 (3.40%)

09/06/17
DADA
09/06/17
INITIATION
Target $26
DADA
Buy
e.l.f. Beauty initiated with a Buy at DA Davidson
DA Davidson analyst Linda Bolton Weiser started e.l.f. Beauty with a Buy rating and $26 price target. The company is "still in its infancy, with much growth opportunity," and the recent pullback in shares offers an "excellent" buying opportunity, the analyst contends.
09/06/17
09/06/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Caterpillar (CAT) initiated with a Neutral at Seaport Global. 2. Liberty Global (LBTYA) initiated with a Buy at Deutsche Bank. 3. TransUnion (TRU) initiated with a Buy at SunTrust. 4. Inovio (INO) initiated with a Buy at Citi. 5. e.l.f. Beauty (ELF) initiated with a Buy at DA Davidson. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/10/17
PIPR
08/10/17
NO CHANGE
Target $32
PIPR
Overweight
e.l.f. Beauty gaining share amid industry deceleration, says Piper Jaffray
Piper Jaffray analyst Erinn Murphy says e.l.f. Beauty's sales in Q2 accelerated from Q1 despite ongoing industry deceleration in the category. She believes, however, that new money will wait to see further evidence of sales acceleration into the second half of 2017. The analyst lowered her price target for the shares to $32 from $34 and keeps an Overweight rating on e.l.f.
08/10/17
JEFF
08/10/17
NO CHANGE
Target $30
JEFF
Buy
e.l.f. Beauty results unlikely to reignite share momentum, says Jefferies
Jefferies analyst Stephanie Wissink says e.l.f. Beauty's Q2 report is likely enough to satisfy current shareholders and revive growth interest, but unlikely to "reignite momentum" in the shares. The analyst keeps a Buy rating on the shares with a $30 price target.
SYY Sysco
$52.91

-0.11 (-0.21%)

06/26/17
BOFA
06/26/17
NO CHANGE
BOFA
Sysco pullback on Amazon concerns overdone, says BofA/Merrill
BofA/Merrill analyst Marisa Sullivan said the pullback in Sysco (SYY) shares following the Amazon.com (AMZN) merger announcement with Whole Foods (WFM) is overdone and provides an attractive buying opportunity. The analyst said B2B food service distribution is more complex than retail and requires a differentiated network and notes many independent customers use Sysco and other large distributors for the value-added products and services offered. Further, Sysco has scale advantages that would be costly and difficult to replicate such as high operational efficiencies and customer density, Sullivan wrote.
06/23/17
JPMS
06/23/17
NO CHANGE
Target $57
JPMS
Overweight
Sysco removed from Analyst Focus List at JPMorgan
JPMorgan analyst John Ivankoe removed Sysco (SYY) from the firm's Analyst Focus List, citing increased risk that Amazon (AMZN) becomes a disruptor to the foodservice distribution industry following its deal to buy Whole Foods. However, Ivankoe keeps an Overweight rating and $57 price target on Sysco shares.
08/15/17
WELS
08/15/17
NO CHANGE
WELS
Sysco has reached attractive entry point, says Wells Fargo
Wells Fargo says that Sysco reported "solid" results. although investors focused on a few negative aspects, including "the looming threat of Amazon (AMZN)," according to the firm. However, the firm believes that the company is executing well and says that the decline in the stock has created an attractive entry point. Wells expects the company's sales to rise 3.7% in fiscal 2018, and it keeps an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

SYBX

Synlogic

$18.73

-0.52 (-2.70%)

09:40
09/19/17
09/19
09:40
09/19/17
09:40
Initiation
Synlogic initiated  »

Synlogic initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KSU

Kansas City Southern

, KORS

Michael Kors

09:40
09/19/17
09/19
09:40
09/19/17
09:40
Options
Unusually active option classes on open September 19th »

Unusual total active…

KSU

Kansas City Southern

KORS

Michael Kors

AAOI

Applied Optoelectronics

$66.29

7.99 (13.71%)

RAD

Rite Aid

NKE

Nike

M

Macy's

EFX

Equifax

INTC

Intel

VIX

Volatility Index S&P 500 Options

AMD

AMD

$13.08

0.56 (4.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 23

    Sep

  • 25

    Sep

  • 26

    Sep

  • 26

    Sep

  • 28

    Sep

  • 03

    Oct

  • 04

    Oct

  • 05

    Oct

  • 16

    Nov

NKE

Nike

09:37
09/19/17
09/19
09:37
09/19/17
09:37
Recommendations
Nike analyst commentary  »

Nike risk/reward remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 26

    Sep

  • 03

    Oct

  • 04

    Oct

SMBK

SmartFinancial

$23.88

0.38 (1.62%)

09:36
09/19/17
09/19
09:36
09/19/17
09:36
Hot Stocks
SmartFinancial, Capstone Bancshares holders approve merger-related proposals »

SmartFinancial and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:35
09/19/17
09/19
09:35
09/19/17
09:35
General news
FX Action: USD-CAD »

FX Action: USD-CAD edged…

PG

Procter & Gamble

09:34
09/19/17
09/19
09:34
09/19/17
09:34
Hot Stocks
Peltz says Procter & Gamble should have bought Method Soap »

Nelson Peltz of Trian…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CORI

Corium

$10.16

0.25 (2.52%)

, NEOS

Neos Therapeutics

$8.70

-0.5 (-5.43%)

09:33
09/19/17
09/19
09:33
09/19/17
09:33
Conference/Events
Mizuho to hold a conference »

Biotechnology CNS Deep…

CORI

Corium

$10.16

0.25 (2.52%)

NEOS

Neos Therapeutics

$8.70

-0.5 (-5.43%)

VYGR

Voyager Therapeutics

$17.36

1.01 (6.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

NVAX

Novavax

$1.12

-0.02 (-1.75%)

09:32
09/19/17
09/19
09:32
09/19/17
09:32
Hot Stocks
Novavax initiates Phase 1/2 trial of NanoFlu vaccine in older adults »

Novavax announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

BSMX

Santander Mexico

09:32
09/19/17
09/19
09:32
09/19/17
09:32
Downgrade
Santander Mexico rating change  »

Santander Mexico…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XPLR

Xplore Technologies

$3.50

-0.2 (-5.41%)

09:31
09/19/17
09/19
09:31
09/19/17
09:31
Hot Stocks
Xplore Technologies secures Android rugged tablet order »

Xplore Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

  • 30

    Nov

SNE

Sony

09:31
09/19/17
09/19
09:31
09/19/17
09:31
Downgrade
Sony rating change  »

Sony downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:30
09/19/17
09/19
09:30
09/19/17
09:30
General news
The U.S. August housing starts report »

The U.S. August housing…

BSX

Boston Scientific

09:29
09/19/17
09/19
09:29
09/19/17
09:29
Hot Stocks
Boston Scientific's HeartLogic Diagnostic shows positive risk detection ability »

Boston Scientific…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UBNT

Ubiquiti

$50.62

-4.335 (-7.89%)

09:28
09/19/17
09/19
09:28
09/19/17
09:28
Hot Stocks
Ubiquiti CEO to host Investor Update on September 26 »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

HQY

HealthEquity

$45.77

0.65 (1.44%)

09:26
09/19/17
09/19
09:26
09/19/17
09:26
Conference/Events
HealthEquity participates in a conference call with Chardan »

Conference call with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

UBNT

Ubiquiti

$50.62

-4.335 (-7.89%)

09:26
09/19/17
09/19
09:26
09/19/17
09:26
Hot Stocks
Ubiquiti Board approves additional $100M stock repurchase program »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

UBNT

Ubiquiti

$50.62

-4.335 (-7.89%)

09:23
09/19/17
09/19
09:23
09/19/17
09:23
Earnings
Ubiquiti narrows Q1 revenue view to $240M-$250M, consensus $234.5M »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

LNDC

Landec

$12.80

-0.2 (-1.54%)

09:22
09/19/17
09/19
09:22
09/19/17
09:22
Hot Stocks
Landec provides update on impact from extreme weather events »

Landec provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

BOBE

Bob Evans

$72.93

1.02 (1.42%)

, POST

Post Holdings

09:19
09/19/17
09/19
09:19
09/19/17
09:19
Hot Stocks
On The Fly: Pre-market Movers »

HIGHER: Bob Evans (BOBE),…

BOBE

Bob Evans

$72.93

1.02 (1.42%)

POST

Post Holdings

AZO

AutoZone

TLGT

Teligent

$6.90

-0.29 (-4.03%)

WBA

Walgreens Boots Alliance

$82.60

0.1 (0.12%)

RAD

Rite Aid

APOG

Apogee Enterprises

$44.98

0.18 (0.40%)

EFX

Equifax

ALDX

Aldeyra

$9.10

0.2 (2.25%)

SNCR

Synchronoss

$16.75

0.64 (3.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 19

    Sep

  • 19

    Sep

  • 21

    Sep

  • 22

    Sep

  • 27

    Sep

  • 27

    Sep

  • 28

    Sep

  • 30

    Oct

  • 19

    Sep

PG

Procter & Gamble

09:19
09/19/17
09/19
09:19
09/19/17
09:19
Hot Stocks
Peltz says not asking for P&G CEO David Taylor to step down »

Nelson Peltz of Trian…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DOX

Amdocs

$64.13

1.64 (2.62%)

09:19
09/19/17
09/19
09:19
09/19/17
09:19
Conference/Events
Amdocs participates in a conference call with Oppenheimer »

Conference call for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TYL

Tyler Technologies

09:18
09/19/17
09/19
09:18
09/19/17
09:18
Hot Stocks
Tyler Technologies selected by Odessa, Texas for ERP solution »

Tyler Technologies signed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SPX

S&P 500

, VIX

Volatility Index S&P 500 Options

09:18
09/19/17
09/19
09:18
09/19/17
09:18
Options
Overnight activity included 97 trades in SPX and 67 trades in VIX »

97 trades were executed…

SPX

S&P 500

VIX

Volatility Index S&P 500 Options

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APD

Air Products

09:16
09/19/17
09/19
09:16
09/19/17
09:16
Hot Stocks
Air Products awarded oxygen supply contract by South Korean chemical company »

Air Products has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TPIC

TPI Composites

$20.98

-0.05 (-0.24%)

, XYL

Xylem

09:15
09/19/17
09/19
09:15
09/19/17
09:15
Conference/Events
Cowen to hold a summit »

Industrial Innovation…

TPIC

TPI Composites

$20.98

-0.05 (-0.24%)

XYL

Xylem

WLDN

Willdan Group

$29.79

0.71 (2.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 19

    Sep

  • 28

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.